3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
113
Urinary Bladder Neoplasms
56
Carcinoma, Non-Small-Cell Lung
52
Cholangiocarcinoma
34
Biliary Tract Neoplasms
32
Neoplasm Metastasis
30
Ovarian Neoplasms
27
Lymphoma, Large B-Cell, Diffuse
26
Breast Neoplasms
25
Lung Neoplasms
24
Neoplasms
23
Carcinoma, Transitional Cell
23
Triple Negative Breast Neoplasms
22
Nasopharyngeal Carcinoma
21
Colorectal Neoplasms
20
Recurrence
17
Non-Muscle Invasive Bladder Neoplasms
16
Gallbladder Neoplasms
15
Fallopian Tube Neoplasms
15
Sarcoma
13
Bile Duct Neoplasms
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Hodgkin Disease
10
Lymphoma
9
Uterine Cervical Neoplasms
8
Adenocarcinoma
8
Stomach Neoplasms
7
Lymphoma, Non-Hodgkin
7
Endometrial Neoplasms
7
Nasopharyngeal Neoplasms
6
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Temozolomide
3
sargramostim
2
montanide ISA 51
2
lutetium Lu 177 dotatate
2
incomplete Freund's adjuvant
2
Sunitinib
2
Octreotide
2
Everolimus
2
Colony-Stimulating Factors
2
Capecitabine
2
sapanisertib
1
lanreotide
1
fludarabine phosphate
1
cabozantinib
1
belzutifan
1
atezolizumab
1
aflibercept
1
abemaciclib
1
X-Rays
1
Salts
1
Phantoms, Imaging
1
PM 01183
1
Methods
1
LY2940680
1
Interleukin-13
1
Injections
1
Immunoglobulin G
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenoma, Islet Cell
×
Gemcitabine
×
1 year
×
Clear all
No trials found.